Author(s)

Susanne Lundin^1,2*, Eva Torkelson³, Marsanna Petersen¹

¹Department of Arts and Cultural Sciences, Lund University, Lund, Sweden.
²Stellenbosch Institute for Advanced Studies (STIAS), Wallenberg Research Centre at Stellenbosch University, Stellenbosch, South Africa.
³Department of Psychology, Lund University, Lund, Sweden.

Although relatively rare, Huntington’s disease (HD) has fatal consequences. There is no cure for the disease, which leads to an early death. Worldwide, scientists are trying to develop therapeutic methods that could cure the disease, including new molecular gene therapeutic methods. At Lund University, research on HD is now about to step from animal models to trials with humans. The project is special in its design since it involves both medical studies and socio-cultural and psychological research to explore and meet the many challenges that experimental trials with HD patients give rise to. The aim of the present study was to investigate the viewpoints of individuals affected by HD on the issues of participation and exerting influence if taking part in a medical study on gene therapy that has not previously been tested on humans. A total of 16 participants, recruited through the national association for HD and through the neurological clinic at Lund University in Sweden, took part in a focus group or in a survey study. A thematic analysis, to explore the transcribed text from the focus groups as well as from the written mail responses, was conducted by means of Nvivo, a program for qualitative data analysis. Results showed three main themes expressing reasons for participation: participation as a last resort, as an activity of hope, and as a way to take responsibility for the development of a cure that will benefit future generations. The responses relating to the question about affected individuals’ view of exerting influence resulted in two themes. The first theme was having a voice when researchers design experiments, which may give a sense of receiving respect. The second was that influence is an essential part of the information process before agreeing to take part in an experimental trail.

Huntington’s Disease, Participation in Clinical Trials, Influence, Focus Groups, Coping

Lundin, S. , Torkelson, E. and Petersen, M. (2016) “With This Disease, You Take Whatever Chances There Are”—A Study on Socio-Cultural and Psychological Aspects of Experiments Regarding Huntington’s Disease. Open Journal of Medical Psychology, 5, 72-87. doi: 10.4236/ojmp.2016.54009.